Solifenacin succinate tablets 2.5 mg “Sawai”, manufactured by Sawai Pharmaceutical, contain Solifenacin succinate. They are used to manage symptoms of overactive bladder such as urinary urgency, frequent urination, and urge incontinence, with a YJ code of 2590011F1052 and a standard of 2.5 mg per tablet.
Solifenacin succinate tablets 2.5 mg “Sawai”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
